|
Potential enteropathogens identified in patients (n = 243) and population controls (n = 124) |
||||
| Study group |
Control group |
odds ratiob |
p-valuec |
|
| Enteropathogens |
No. of findings(%) |
No. of findings (%) |
adjusted for age and sex (95 % CI) |
|
|
|
||||
| Virusesa |
178 (73.3) |
57 (46.0) |
3.27 (2.1 to 5.2) |
< 0.0001 |
| Rotavirus |
133 (54.7) |
15 (12.1) |
7.73 (4.2 to 14.2) |
< 0.0001 |
| Adenovirus |
67 (27.6) |
39 (31.5) |
1.12 (0.7 to 1.9) |
0.7 |
| Norovirus |
23 (9.5) |
11 (8.9) |
0.84 (0.4 to 1.8) |
0.7 |
| Astrovirus |
11 (4.5) |
2 (1.6) |
2.53 (0.6 to 11.7) |
0.2 |
| Parasitesa |
12 (4.9) |
16 (12.9) |
0.56 (0.2 to 1.3) |
0.2 |
| Giardia lamblia |
9 (3.7) |
12 (9.7) |
0.56 (0.2 to 1.5) |
0.2 |
| Cryptosporidium sp. |
1 (0.4) |
1 (0.8) |
- |
- |
| Hymenolepis nana |
2 (0.8) |
1 (0.8) |
- |
- |
| Strongyloides stercoralis |
1 (0.4) |
1 (0.8) |
- |
- |
| Ancylostoma duodenale |
1 (0.4) |
1 (0.8) |
- |
- |
| Bacteriaa |
12 (4.8) |
2 (1.6) |
4.8 (0.9 to 27.0) |
0.07 |
| Salmonella enterica sp. |
6 (2.4) |
0 (0.0) |
- |
- |
| Campylobacter sp. |
2 (0.8) |
1 (0.8) |
- |
- |
| Shigella sp. |
4 (1.6) |
1 (0.8) |
- |
- |
|
a including double infections b "-" odds ratio was not computed if n ≤ 1 in study or control group; c "-" not significant | ||||
Reither et al. BMC Infectious Diseases 2007 7:104 doi:10.1186/1471-2334-7-104 |
||||